Prevalence of statin-drug interactions in older people: a systematic review

European Journal of Clinical Pharmacology
Michele ThaiDanijela Gnjidic

Abstract

Statins are among the most frequently prescribed medications internationally. Older people are commonly prescribed multiple medications and are at an increased risk of drug-drug interactions, including statin-drug interactions. The aim of this study was to conduct a systematic review of current evidence on the prevalence of statin-drug interactions in older people. A systematic search of observational studies in Embase, Medline, and PubMed was conducted. Articles were included if they were published in English during the period July 2000-July 2014 and reported on the prevalence of statin-drug interactions in people over 65 years of age. Two reviewers independently assessed the articles for eligibility and extracted the data. The search returned 1556 eligible articles. A total of 19 articles met the inclusion criteria. In studies (n = 7) that focused on statin users only, the prevalence of potential statin-drug interactions assessed using different measures ranged from 0.19 to 33.0 %. In studies that examined drug interactions across a population of both statin users and non-users (n = 12), the prevalence of potential statin-drug interactions ranged from 0.1 to 7.1 % (n = 8), and the prevalence of clinically relevant statin-drug...Continue Reading

References

Jul 2, 2004·Journal of Managed Care Pharmacy : JMCP·Jerilyn B Petropoulos, Cristina E Bello-Quintero
Jul 27, 2005·European Journal of Clinical Pharmacology·Nadia PiacentiniUNKNOWN UVEC group
Apr 4, 2006·The American Journal of Cardiology·Michael B Bottorff
Oct 26, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kathlyn J RonaldsonIan W Boyd
Dec 13, 2006·Pharmacoepidemiology and Drug Safety·Matthijs L BeckerBruno H Ch Stricker
Dec 15, 2006·British Journal of Clinical Pharmacology·Agnes I Vitry
Dec 21, 2006·Clinical Pharmacology and Therapeutics·Pertti J NeuvonenJanne T Backman
May 25, 2007·Fundamental & Clinical Pharmacology·Sarah N HilmerDavid G Le Couteur
Aug 19, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Caroline G P RobertsAnnabelle Rodriguez
Sep 18, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kristina Johnell, Inga Klarin
Jan 5, 2008·Journal of the American College of Cardiology·Jonathan AfilaloMark J Eisenberg
Apr 17, 2008·Pharmacy World & Science : PWS·Priska VonbachJürg H Beer
Dec 26, 2008·JAMA : the Journal of the American Medical Association·Dima M QatoStacy Tessler Lindau
Jun 3, 2009·Clinics·Marcos A S CabreraSara L Rodrigues
Jul 27, 2010·British Journal of Clinical Pharmacology·Elizabeth E RougheadAndrew L Gilbert
Oct 6, 2010·Pharmacy World & Science : PWS·Vesna Bacic-VrcaDario Rahelic
Jun 21, 2011·Current Medical Research and Opinion·Alberto Corsini, Richard Ceska
Sep 14, 2011·Pharmacoepidemiology and Drug Safety·Kjell H HalvorsenSabine Ruths
Nov 15, 2011·The American Journal of Geriatric Pharmacotherapy·Lisa E Hines, John E Murphy
Jan 13, 2012·Pharmacoepidemiology and Drug Safety·Ameet BakhaiCathy Emmas
Jan 20, 2012·The Medical Journal of Australia·Tessa K MorganJoanne Barnes
Mar 16, 2012·Expert Opinion on Drug Safety·Matilda Florentin, Moses S Elisaf
Aug 8, 2012·Expert Opinion on Drug Safety·Stefano Bellosta, Alberto Corsini
Sep 12, 2012·International Journal of Clinical Pharmacy·María Espinosa-BoschPaloma Villacorta-Linaza
Mar 27, 2013·Clinical and Experimental Pharmacology & Physiology·Danijela Gnjidic, Kristina Johnell
May 18, 2013·Drugs & Aging·Marianne LeaEspen Molden
Jun 20, 2013·The Annals of Pharmacotherapy·Wei-Hsuan Lo-CiganicJoseph T Hanlon
Jul 3, 2013·International Journal of Clinical Pharmacy·Cheng Kin LaoAlexandre Chan
Feb 14, 2014·Journal of the American Geriatrics Society·Zachary A MarcumJulie M Donohue
Mar 22, 2014·European Journal of Clinical Pharmacology·Branislava PopovićVera Vlahović-Palčevski

❮ Previous
Next ❯

Citations

Dec 20, 2017·European Journal of Clinical Pharmacology·Camille MorivalPascal Le Corre
Jul 17, 2019·Basic & Clinical Pharmacology & Toxicology·Carina Tukukino, Susanna M Wallerstedt
Apr 20, 2019·International Journal of Cancer. Journal International Du Cancer·Yu LiuLiang-Hao Hu
Nov 7, 2019·São Paulo Medical Journal = Revista Paulista De Medicina·Bianca Menezes DiasAdriano Max Moreira Reis
Dec 22, 2020·Chemosensory Perception·Kathleen E Bainbridge, Danita Byrd-Clark
Mar 25, 2021·Expert Opinion on Drug Metabolism & Toxicology·Luis Fernando Valladales-RestrepoJorge Enrique Machado-Alba
May 6, 2021·Pharmacoepidemiology and Drug Safety·Emilie BorneBruno Michel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.